Proteus Ends Deal with Otsuka, Refocuses on Oncology and Infectious Diseases Treatment

Proteus Otsuka end deal
Proteus has prematurely ended its high profile $88 million deal with Otsuka, reports MobiHealthNews. Proteus’ CEO, Andrew Thompson, told STAT News that the company and Otsuka Pharmaceutical have ended a […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleLivongo Partners with Dexcom to Integrate Dexcom’s CGM System into their Platform
Next articleSensoria Announces Total End-to-End Knee Replacement Surgery at the CES 2020
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)wearable-technologies.com.